Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer

Surgery

Volumn 133, Issue 3, 2003, Pages 300-308

  Kawakami, Masayo ^a   Furuhata, Tomohisa ^b   Kimura, Yasutoshi ^b   Yamaguchi, Koji ^b   Hata, Fumitake ^b   Sasaki, Kazuaki ^b   Hirata, Koichi ^b  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR PROTEIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3;

ADULT; AGED; ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOLOGICAL TRAIT; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SENSITIVITY ANALYSIS;

EID: 0037351882     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.45     Document Type: Article

References (24)

1. Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995;333:1757-63.
2. Vaukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J 1996;15:290-8.
3. Lee J, Gray A, Yuan J, Luoh S, Avraham H, Wood W. Vascular endorhelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A 1996;93:1988-92.
4. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-5.
5. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, et al. VEGF and VEGF-C: specific introduction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997;188:96-109.
6. Kaipanen A, Korhonen J, Mustonen T, van Hinsbergh V, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 1995;92:3566-70.
7. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, et al. Signaling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001;20:1223-31.
8. Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S, et al. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 1999;90:977-81.
9. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, et al. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000;83:887-91.
10. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, et al. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999;5:1823-9.
11. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 1999;155:1967-76.
12. Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 1999;126:1056-61.
13. Ohta Y, Nozawa H, Tanaka Y, Oda M, Watamane Y. Increased vascular endothelial growth factor and vascular endothelial growth factor-C and decreased nm23 expression associated with microdissemination in the lymph nodes in stage 1 non-small cell lung cancer. J Thorac Cardiovasc Surg 2000;119:804-13.
14. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999;80:309-13.
15. Yonemura Y, Fushida S, Bando E, Kinoshita K, Miwa K, Endo Y, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR-3) in gastric cancer. Eur J Cancer 2001;37:918-23.
16. Kobashima A, Maehara Y, Kakeji Y, Sugimachi K. Over-expression of vascular endothelial growth factor C is related to lymphogenous metastasis in early gastric carcinoma. Oncology 2001;160:146-50.
17. Bieche I, Olivi M, Champeme MH, Vidaud D, Lidereau R, Vidaud M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int J Cancer 1998;78:661-6.
18. Fink L, Seeger W, Ermert L, Hanze J, Stahl U, Grimminger F, et al. Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998;4:1329-33.
19. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-94.
20. Gerard CJ, Olsson K, Ramanathan R, Reading C, Hanania EG. Improved quantification of minimal residual diseases in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarily determining region standards. Cancer Res 1998;58:3957-64.
21. Kreuzer KA, Lass U, Bohn A, Landt O, Schmidt CA. LightCycler technology for the quantification of bcr/abl fusion transcripts. Cancer Res 1999;59:3171-4.
22. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999;154:1381-90.
23. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of VEGFR-3 in human vascular tumors. Cancer 1999;86:2406-12.
24. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 2000;14:2087-96.